Filleron T - Search Results

1

Prognostic factors of young women (≤ 35 years) with node positive breast cancer: possible influence on post-therapeutic follow-up.

Filleron T, Md FD, Kramar A, Spielmann M, Levy C, Fumoleau P, Canon JL, Martin AL, Roché H. Filleron T, et al. Bull Cancer. 2013 Jul-Aug;100(7-8):22-9. doi: 10.1684/bdc.2013.1791. Bull Cancer. 2013. PMID: 23822935

2

Optimization of follow-up timing from study of patterns of first failure after primary treatment. An example from patients with NSCLC: a study of the REACT working group of ESTRO.

Ataman OU, Barrett A, Filleron T, Kramar A; ESTRO-REACT Group. Ataman OU, et al. Among authors: filleron t. Radiother Oncol. 2006 Jan;78(1):95-100. doi: 10.1016/j.radonc.2005.09.012. Epub 2005 Oct 26. Radiother Oncol. 2006. PMID: 16256232 Clinical Trial.

3

Tipifarnib plus tamoxifen in tamoxifen-resistant metastatic breast cancer: a negative phase II and screening of potential therapeutic markers by proteomic analysis.

Dalenc F, Doisneau-Sixou SF, Allal BC, Marsili S, Lauwers-Cances V, Chaoui K, Schiltz O, Monsarrat B, Filleron T, Renée N, Malissein E, Meunier E, Favre G, Roché H. Dalenc F, et al. Among authors: filleron t. Clin Cancer Res. 2010 Feb 15;16(4):1264-71. doi: 10.1158/1078-0432.CCR-09-1192. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145184 Clinical Trial.

4

An R function to non-parametric and piecewise analysis of competing risks survival data.

Filleron T, Laplanche A, Boher JM, Kramar A. Filleron T, et al. Comput Methods Programs Biomed. 2010 Oct;100(1):24-38. doi: 10.1016/j.cmpb.2010.02.004. Epub 2010 Mar 24. Comput Methods Programs Biomed. 2010. PMID: 20338662

5

DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability.

Lemée F, Bergoglio V, Fernandez-Vidal A, Machado-Silva A, Pillaire MJ, Bieth A, Gentil C, Baker L, Martin AL, Leduc C, Lam E, Magdeleine E, Filleron T, Oumouhou N, Kaina B, Seki M, Grimal F, Lacroix-Triki M, Thompson A, Roché H, Bourdon JC, Wood RD, Hoffmann JS, Cazaux C. Lemée F, et al. Among authors: filleron t. Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13390-5. doi: 10.1073/pnas.0910759107. Epub 2010 Jul 12. Proc Natl Acad Sci U S A. 2010. PMID: 20624954 Free PMC article.

6

Formation of the eIF4F translation-initiation complex determines sensitivity to anticancer drugs targeting the EGFR and HER2 receptors.

Zindy P, Bergé Y, Allal B, Filleron T, Pierredon S, Cammas A, Beck S, Mhamdi L, Fan L, Favre G, Delord JP, Roché H, Dalenc F, Lacroix-Triki M, Vagner S. Zindy P, et al. Among authors: filleron t. Cancer Res. 2011 Jun 15;71(12):4068-73. doi: 10.1158/0008-5472.CAN-11-0420. Epub 2011 Apr 15. Cancer Res. 2011. PMID: 21498638

7

Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer.

Martinet L, Garrido I, Filleron T, Le Guellec S, Bellard E, Fournie JJ, Rochaix P, Girard JP. Martinet L, et al. Among authors: filleron t. Cancer Res. 2011 Sep 1;71(17):5678-87. doi: 10.1158/0008-5472.CAN-11-0431. Epub 2011 Aug 16. Cancer Res. 2011. PMID: 21846823

8

The prognostic significance of lymphovascular invasion on biopsy specimens in lung cancer treated with definitive chemoradiotherapy.

Massabeau C, Filleron T, Wakil G, Rouquette I, Bachaud JM, Leguellec S, Delisle MB, Toulas C, Mazieres J, Cohen-Jonathan Moyal E. Massabeau C, et al. Among authors: filleron t. Clin Lung Cancer. 2012 Jan;13(1):59-67. doi: 10.1016/j.cllc.2011.06.011. Clin Lung Cancer. 2012. PMID: 21856239

9

Designing group sequential randomized clinical trials with time to event end points using a R function.

Filleron T, Gal J, Kramar A. Filleron T, et al. Comput Methods Programs Biomed. 2012 Oct;108(1):113-28. doi: 10.1016/j.cmpb.2012.02.002. Epub 2012 Mar 8. Comput Methods Programs Biomed. 2012. PMID: 22405523

10

Failure event types and prognostic factors after node-positive breast cancer in patients treated by adjuvant chemotherapy: impact on follow-up.

Filleron T, Kramar A, Dalenc F, Spielmann M, Fumoleau P, Kerbrat P, Martin AL, Roché H. Filleron T, et al. Bull Cancer. 2012 Jun;99(6):E64-74. doi: 10.1684/bdc.2012.1592. Bull Cancer. 2012. PMID: 22641367 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters